Alpha Crest Capital Management LLC Charles River Laboratories International, Inc. Transaction History

Alpha Crest Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $75,895 - $104,224	416 Added 42.8%	1,388 $273,000
Q2 2022 Aug 11, 2022	SELL	$204.13 - $302.4 $335,181 - $496,540	-1,642 Reduced 62.82%	972 $208,000
Q1 2022 May 12, 2022	SELL	$255.51 - $362.11 $448,931 - $636,227	-1,757 Reduced 40.2%	2,614 $742,000
Q4 2021 Feb 09, 2022	BUY	$351.38 - $448.68 $1.14 Million - $1.45 Million	3,240 Added 286.47%	4,371 $1.65 Million
Q3 2021 Nov 10, 2021	BUY	$372.64 - $458.3 $421,455 - $518,337	1,131 New	1,131 $467,000
Q3 2020 Nov 12, 2020	SELL	$175.56 - $226.45 $212,954 - $274,683	-1,213 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$118.84 - $189.72 $379,337 - $605,586	-3,192 Reduced 72.46%	1,213 $211,000
Q1 2020 May 13, 2020	BUY	$98.9 - $178.34 $76,944 - $138,748	778 Added 21.45%	4,405 $556,000
Q4 2019 Feb 12, 2020	BUY	$126.05 - $152.76 $457,183 - $554,060	3,627 New	3,627 $554,000
Q1 2019 May 10, 2019	SELL	$104.82 - $146.73 $566,028 - $792,342	-5,400 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$105.09 - $137.23 $567,486 - $741,042	5,400 New	5,400 $611,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.